EICHORCondition: Coronary Heart Disease (CHD) · Sponsor: Amgen
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
This study will assess the effect of lowering low-density lipoprotein cholesterol (LDL-C) with evolocumab on major cardiovascular events in adults without a prior myocardial infarction (MI) or stroke who are at high risk of a cardiovascular event.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| North Alabama Research Center LLC | Athens, Alabama, United States | — |
| Cardiovascular Associates | Birmingham, Alabama, United States | — |
| Heart Center Research LLC | Huntsville, Alabama, United States | — |
| Mobile Heart Specialists PC | Mobile, Alabama, United States | — |
| Arkansas Cardiology | Little Rock, Arkansas, United States | — |
| Central Arkansas Veterans Healthcare System | Little Rock, Arkansas, United States | — |
| Cardiovascular Research Foundation of Southern California | Beverly Hills, California, United States | — |
| Westside Medical Associates of Los Angeles | Beverly Hills, California, United States | — |
| West Coast Research LLC | Dublin, California, United States | — |
| Desert Oasis Healthcare Medical Group | Palm Springs, California, United States | — |
| Covigilant Research, LLC | Riverside, California, United States | — |
| Sierra Clinical Research | Roseville, California, United States | — |
+ 840 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03872401